Atlas Trials

Study Comparing Adapalene Gel 0.3% to Differin® and Both to a Placebo Control in Treatment of Acne Vulgaris

Clinical trial NCT02411942 · COMPLETED

Trial details

NCT number
NCT02411942
Sponsor
Sun Pharmaceutical Industries, Inc.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Acne Vulgaris
Start date
2014-08-01
Primary completion
2015-02-01
Enrollment
753

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.